While missing an EU Joint Scientific Consultation (JSC) is suboptimal, the greater strategic concern...
Read moreFrom 1 April 2026, AIFA’s updated HTA guidelines will come into effect, making ...
Read moreOur previous article explored how TrumpRx might influence drug pricing in the US, the potential ...
Read moreManufacturers looking to optimise access for their orphan drugs need to navigate a complex environme...
Read moreIn 2026, U.S. policy shifts will link domestic US prices to internatio...
Read moreThe year 2026 marks a significant milestone for the European Union’s (EU) Health Tec...
Read moreHave you ever wondered what separates the organisations that consistently secure unhindere...
Read moreThe Top Market Access Trends for 2026 The market access trends 2026 are being shaped by increasing g...
Read more2025 was a pivotal year for market access, marked by the growing convergence between scientific inno...
Read moreClinical innovation has never moved faster. Tools like single-arm designs, novel surrogates, and ada...
Read more